Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
Top Cited Papers
- 20 November 2007
- journal article
- gynecologic cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (33), 5165-5171
- https://doi.org/10.1200/jco.2007.11.5345
Abstract
Purpose Vascular endothelial growth factor (VEGF) seems to be a promoter of tumor progression for epithelial ovarian cancer (EOC) and primary peritoneal cancer (PPC). We conducted a phase II trial ...Keywords
This publication has 25 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and TherapyJournal of Clinical Oncology, 2002
- Vascular Endothelial Growth Factor Immunoneutralization Plus Paclitaxel Markedly Reduces Tumor Burden and Ascites in Athymic Mouse Model of Ovarian CancerThe American Journal of Pathology, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Molecular and biological properties of vascular endothelial growth factorJournal of Molecular Medicine, 1999
- Optimal flexible designs in phase II clinical trialsStatistics in Medicine, 1998
- Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude MiceJNCI Journal of the National Cancer Institute, 1998
- Vascular endothelial growth factor expression in early stage ovarian carcinomaCancer, 1997
- Prognostic and predictive value of tumour angiogenesis in ovarian carcinomasInternational Journal of Cancer, 1996
- Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association.Cell Metabolism, 1994